Nutex Health Inc. reported significant year-over-year growth in its preliminary third quarter 2025 results. The company saw an estimated 258.8% increase in cash collections compared to the same period in 2024, which it attributed to improved revenue cycle management, payer mix, and higher patient acuity. Nutex Health is working to file its delinquent Form 10-Q for the period ended June 30, 2025, and anticipates submitting both the June and September 2025 quarterly reports by the deadline specified in the Nasdaq Exception Notice. The company emphasized that these preliminary financial metrics are subject to change pending final accounting adjustments and audit completion.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutex Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001479681-25-000085), on October 20, 2025, and is solely responsible for the information contained therein.